Wave Life Sciences (WVE) Receivables - Other (2018 - 2019)

Wave Life Sciences' (WVE) quarterly Receivables - Other came in at $20.0 million in Q4 2019, up 100.0% YoY from $10.0 million in Q4 2018, and little changed on a QoQ basis from $20.0 million in Q3 2019.

Wave Life Sciences (WVE) Receivables - Other (2018 - 2019) Analysis & Trends

Wave Life Sciences (WVE) has 2 years of Receivables - Other data on file, last reported at $20.0 million in Q4 2019.

  • Quarterly Receivables - Other rose 100.0% year-over-year to $20.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $20.0 million (up 100.0% YoY) and the FY2019 annual result came in at $20.0 million, up 100.0% from the prior year.
  • Receivables - Other held at $20.0 million in Q4 2019, from $20.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $20.0 million in Q2 2019 to a low of $10.0 million in Q2 2018.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Wave Life Sciences 1.05 Bn 677.62 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 20.00 Mn
Dec 31, 2019 20.00 Mn
Sep 30, 2019 20.00 Mn
Sep 30, 2019 20.00 Mn
Jun 30, 2019 20.00 Mn
Jun 30, 2019 20.00 Mn
Mar 31, 2019 10.00 Mn
Mar 31, 2019 10.00 Mn
Dec 31, 2018 10.00 Mn
Dec 31, 2018 10.00 Mn
Sep 30, 2018 10.00 Mn
Sep 30, 2018 10.00 Mn
Jun 30, 2018 10.00 Mn
Jun 30, 2018 10.00 Mn